Lexicon Pharmaceuticals to Participate in the 41st Annual JP Morgan Healthcare Conference

On January 6, 2023 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) reported its participation in the 41st Annual JP Morgan Healthcare Conference, taking place January 9-12, 2023 (Press release, Lexicon Pharmaceuticals, JAN 6, 2023, View Source [SID1234625971]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Lonnel Coats, Lexicon’s chief executive officer, will make a company presentation which will be available on-demand beginning at 3:00 pm ET/12:00 pm PST on Thursday, January 12, 2023.

A simultaneous webcast of the presentation will be available in the "Events" section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be available for two weeks following the original on-demand date.